	US 12,109,250 B2
	Methods and compositions for treatment of bone, skin, subcutaneous, mucosal and/or submucosal cancer by percutaneous and/or transmucosal administration of interferon
Guangwen Wei, Chengdu (CN)
Assigned to SUPERLAB FAR EAST LIMITED, Tortola (VG)
Filed by SUPERLAB FAR EAST LIMITED, Tortola (VG)
Filed on Dec. 29, 2020, as Appl. No. 17/136,656.
Application 17/136,656 is a continuation of application No. 16/044,582, filed on Jul. 25, 2018, granted, now 10,874,716.
Application 16/044,582 is a continuation of application No. 14/759,483, abandoned, previously published as PCT/CN2014/070212, filed on Jan. 7, 2014.
Claims priority of provisional application 61/779,711, filed on Mar. 13, 2013.
Claims priority of provisional application 61/749,570, filed on Jan. 7, 2013.
Prior Publication US 2021/0260164 A1, Aug. 26, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/21 (2006.01); A61K 9/00 (2006.01); A61K 31/5377 (2006.01); A61K 31/7068 (2006.01); A61K 33/243 (2019.01); A61K 38/39 (2006.01); A61K 45/06 (2006.01); A61M 11/00 (2006.01)

CPC A61K 38/21 (2013.01) [A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 9/0073 (2013.01); A61K 31/5377 (2013.01); A61K 31/7068 (2013.01); A61K 33/243 (2019.01); A61K 38/39 (2013.01); A61K 45/06 (2013.01); A61M 11/00 (2013.01)]

19 Claims

1. A method of treating skin cancer, subcutaneous cancer, mucosal carcinoma, submucosal carcinoma, and/or bone pain associated with cancer in a subject, comprising administering to the subject an effective amount of an anti-cancer interferon, wherein the interferon comprises an amino acid sequence of SEQ ID NO: 1.